BD Announces Acquisition of Protein Separation Technology From FFE Weber GmbH

The need to improve and eventually standardize the preanalytical process leading to protein analytics is significant," said William Kozy, President, BD Diagnostics. "The inherent complexity and dynamic range of proteins within a human plasma sample make it difficult to detect the very low abundance proteins that may prove indicative of a disease state. New techniques for both clinical sample collection and processing are needed. This novel protein separation technology we have acquired from FFE Weber GmbH provides an important preanalytical separation step that will help proteomics researchers to find, characterize and validate new classes of biomarkers."

BD Announces Acquisition of Protein Separation Technology From FFE Weber GmbH

No comments:

Blog Archive